R. Moidl et al., INCREASED PULMONARY FLOW VELOCITIES IN OVERSIZED HOMOGRAFTS IN PATIENTS AFTER THE ROSS PROCEDURE, European journal of cardio-thoracic surgery, 12(4), 1997, pp. 569-572
Objective: Between September 1991 and July 1996, 60 patients (mean age
29.8 +/- 9 years; range 5-57) underwent aortic root replacement with
pulmonary autograft, a viable biologic and nondegenerating substitute.
The pulmonary root was replaced with cryopreserved homografts from ca
rdiac transplant recipients. The aim of this study was to evaluate dif
ferences in early valve function of viable and cryopreserved allograft
s. Methods: All patients had Doppler echocardiographic examinations pr
eoperatively, at discharge from hospital and 54 patients at 1 year fol
low-up. We measured aortic and pulmonary peak flow velocities with con
tinuous and pulsed-wave Doppler, and graded aortic and pulmonary insuf
ficiency (AI, PI) with color Doppler flow (grade 0-IV). Intraoperative
ly, the diameters of the pulmonary root and the pulmonary homograft we
re measured with standard valve probes and matched to body surface are
a. Results: Pulmonary peak how velocity (PVmax) increased significantl
y from preoperative 0.87 +/- 0.11 m/s to 1.30 +/- 0.34 m/s postoperati
vely (P < 0.001). The implanted homografts (mean 25.9 +/- 2.4 mm) were
larger than their native pulmonary diameter (mean 23.3 +/- 1.8 mm) in
all patients. Homograft size matched for body surface area (BSA) did
not correlate with increased PVmax. There was a significant increase o
f PVmax at follow-up (FU) since discharge, also 1.83 +/- 0.53 m/s; P <
0.001). Pulsed-wave Doppler demonstrates that increase of PVmax is lo
cated directly at the homograft leaflets and not at the anastomoses. A
ortic peak flow velocities (AV(max)) were normal postoperatively and a
t FU (post = 1.35 +/- 0.35 m/s; FU = 1.17 +/- 0.27 m/s). There was no
significant change in AI or PI since discharge (AI FU = 0.8 +/- 0.4; P
I FU = 0.7 +/- 0.5. Eight patients with fever and symptoms diagnosed a
s post-pericardiotomy syndrome had significantly higher PVmax at FU (P
Vmax 2.41 +/- 0.40 m/s; P < 0.02). Conclusions: The Ross procedure lea
ds to normal AV(max) but significant increase of PVmax even in oversiz
ed cryopreserved homografts immediately after surgery. Further increas
e of PVmax without changes in AV(max) in the first year demonstrates t
hat changes in how velocities are valve related and not due to increas
e in cardiac output. Further investigations will be necessary to deter
mine whether this observation is due to valve rejection or early leafl
et degeneration and treatment with immunosuppressive therapy is warran
ted. (C) 1997 Elsevier Science B.V.